GeneDx Holdings (WGSWW) Other Non Operating Income (2020 - 2026)

GeneDx Holdings has disclosed Other Non Operating Income across 7 years of filings, most recently posting -$6.6 million for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 3241.15% year-over-year to -$6.6 million; the TTM figure through Mar 2026 stood at -$11.1 million (up 13.63% YoY), while the FY2025 annual figure was -$4.3 million, up 66.83% from the prior year.
• Other Non Operating Income slipped to -$6.6 million in Q1 2026, from -$4.6 million in the prior quarter.
• Over the last five years, Other Non Operating Income for WGSWW reached as high as $2.7 million in Q1 2023 and fell as low as -$13.5 million in Q2 2024.
• The 5-year median for Other Non Operating Income is $500.0 (2022), against an average of -$1.4 million.
• Annual changes were most pronounced in 2023 — Other Non Operating Income sank 56800.0% — and 2025, when it soared 464.86%.
• A 5-year view of Other Non Operating Income shows it stood at -$1000.0 in 2022, then tumbled by 4800.0% to -$49000.0 in 2023, then tumbled by 1357.14% to -$714000.0 in 2024, then tumbled by 543.0% to -$4.6 million in 2025, then sank by 43.0% to -$6.6 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$6.6 million, -$4.6 million, and -$174000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.